MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate
- PMID: 28994615
- PMCID: PMC5695735
- DOI: 10.1089/gtmb.2017.0124
MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate
Abstract
Aim: To investigate the relationships of polymorphisms in genes whose protein products are related in the metabolic pathway of folic acid, particularly MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C, and disease activity in Mexican patients with rheumatoid arthritis (RA) treated with methotrexate (MTX).
Materials and methods: Sixty-eight patients with RA were included in the study who were being treated with MTX, either with or without other drugs. In addition to general data, disease activity was measured by the disease activity score 28 (DAS28). Single nucleotide polymorphisms (SNPs) genotyping was performed by allelic discrimination using real-time polymerase chain reaction.
Results: Differences in genotype (homozygotic or heterozygotic for each allele), allele distributions, and phenotype were not statistically different between the RA group and control populations. We did not find any association between the studied polymorphisms and disease activity nor with the intragroup variables (e.g., clinical activity, body mass index, and single- or combined-drug treatment) or between genetic markers; we also did not find any association within the RA group or between the RA group and control populations.
Conclusion: Additional studies of more polymorphisms related to this or other metabolic pathways are required to determine the influence of genetics on disease activity in RA.
Keywords: DAS28; MTHFR; MTRR; RFC1; methotrexate; rheumatoid arthritis.
Conflict of interest statement
No competing financial interests exist.
Figures

Similar articles
-
MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies.Clin Rheumatol. 2020 Aug;39(8):2267-2279. doi: 10.1007/s10067-020-05031-5. Epub 2020 Mar 14. Clin Rheumatol. 2020. PMID: 32170488
-
Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):385-93. doi: 10.1007/s13318-015-0288-z. Eur J Drug Metab Pharmacokinet. 2016. PMID: 26077125
-
Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G Polymorphisms with Neural Tube Defects in Tunisian Parents.Pathobiology. 2019;86(4):190-200. doi: 10.1159/000499498. Epub 2019 Jun 25. Pathobiology. 2019. PMID: 31238314
-
Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.OMICS. 2012 Nov;16(11):589-95. doi: 10.1089/omi.2011.0142. Epub 2012 Oct 24. OMICS. 2012. PMID: 23095111
-
Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.Clin Drug Investig. 2010;30(2):101-8. doi: 10.2165/11531070-000000000-00000. Clin Drug Investig. 2010. PMID: 20067328 Review.
Cited by
-
Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms and five related serum molecular levels in 2587 patients: Associated differentially with adverse pregnancy.Mol Biol Rep. 2024 Sep 26;51(1):1014. doi: 10.1007/s11033-024-09948-x. Mol Biol Rep. 2024. PMID: 39325209
-
MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies.Clin Rheumatol. 2020 Aug;39(8):2267-2279. doi: 10.1007/s10067-020-05031-5. Epub 2020 Mar 14. Clin Rheumatol. 2020. PMID: 32170488
-
Co-Occurring Methylenetetrahydrofolate Reductase (MTHFR) rs1801133 and rs1801131 Genotypes as Associative Genetic Modifiers of Clinical Severity in Rett Syndrome.Brain Sci. 2024 Jun 21;14(7):624. doi: 10.3390/brainsci14070624. Brain Sci. 2024. PMID: 39061365 Free PMC article.
-
Severe Adverse Toxic Effects of Low-Dose Methotrexate Treatment on an Ectopic Pregnancy Patient With Methylenetetrahydrofolate Reductase Mutations: A Case Report.Front Med (Lausanne). 2021 Nov 18;8:738315. doi: 10.3389/fmed.2021.738315. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869432 Free PMC article.
-
Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population.Front Pharmacol. 2018 Nov 28;9:1390. doi: 10.3389/fphar.2018.01390. eCollection 2018. Front Pharmacol. 2018. PMID: 30546311 Free PMC article.
References
-
- Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324 - PubMed
-
- Barrera Cruz A, Beltran Castillo J, Blanco Favela F, et al. (2010) Diagnóstico y Tratamiento de Artritis Reumatoide del Adulto. México: Secretaria de Salud
-
- Boughrara W, Aberkane M, Fodil M, et al. (2015) Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: a case-control study. Acta Reumatol Port 40:363–371 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical